7697 related articles for article (PubMed ID: 2448650)
1. 10-Ethyl-10-deaza-aminopterin: structural design and biochemical, pharmacologic, and antitumor properties.
Sirotnak FM; Schmid FA; Samuels LL; DeGraw JI
NCI Monogr; 1987; (5):127-31. PubMed ID: 2448650
[TBL] [Abstract][Full Text] [Related]
2. Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor models.
Schmid FA; Sirotnak FM; Otter GM; DeGraw JI
Cancer Treat Rep; 1987; 71(7-8):727-32. PubMed ID: 3607784
[TBL] [Abstract][Full Text] [Related]
3. New folate analogs of the 10-deaza-aminopterin series: markedly increased antitumor activity of the 10-ethyl analog compared to the parent compound and methotrexate against some human tumor xenografts in nude mice.
Schmid FA; Sirotnak FM; Otter GM; DeGraw JI
Cancer Treat Rep; 1985 May; 69(5):551-3. PubMed ID: 4005878
[TBL] [Abstract][Full Text] [Related]
4. New folate analogs of the 10-deaza-aminopterin series. Further evidence for markedly increased antitumor efficacy compared with methotrexate in ascitic and solid murine tumor models.
Sirotnak FM; DeGraw JI; Schmid FA; Goutas LJ; Moccio DM
Cancer Chemother Pharmacol; 1984; 12(1):26-30. PubMed ID: 6690070
[TBL] [Abstract][Full Text] [Related]
5. Further evidence for a basis of selective activity and relative responsiveness during antifolate therapy of murine tumors.
Sirotnak FM; Donsback RC
Cancer Res; 1975 Jul; 35(7):1737-44. PubMed ID: 1169115
[TBL] [Abstract][Full Text] [Related]
6. Antitumor properties of a new folate analog, 10-deaza-aminopterin, in mice.
Sirotnak FM; DeGraw JI; Moccio DM; Dorick DM
Cancer Treat Rep; 1978 Jul; 62(7):1047-52. PubMed ID: 688246
[TBL] [Abstract][Full Text] [Related]
7. Markedly improved efficacy of edatrexate compared to methotrexate in a high-dose regimen with leucovorin rescue against metastatic murine solid tumors.
Sirotnak FM; Otter GM; Schmid FA
Cancer Res; 1993 Feb; 53(3):587-91. PubMed ID: 8425192
[TBL] [Abstract][Full Text] [Related]
8. New folate analogs of the 10-deaza-aminopterin series. Basis for structural design and biochemical and pharmacologic properties.
Sirotnak FM; DeGraw JI; Moccio DM; Samuels LL; Goutas LJ
Cancer Chemother Pharmacol; 1984; 12(1):18-25. PubMed ID: 6690069
[TBL] [Abstract][Full Text] [Related]
9. A new analogue of 10-deazaaminopterin with markedly enhanced curative effects against human tumor xenografts in mice.
Sirotnak FM; DeGraw JI; Colwell WT; Piper JR
Cancer Chemother Pharmacol; 1998; 42(4):313-8. PubMed ID: 9744777
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity, uptake, polyglutamate formation, and antileukemic effects of 8-deaza analogues of methotrexate and aminopterin in mice.
Kuehl M; Brixner DI; Broom AD; Avery TL; Blakley RL
Cancer Res; 1988 Mar; 48(6):1481-8. PubMed ID: 2449950
[TBL] [Abstract][Full Text] [Related]
11. Similar differential for total polyglutamylation and cytotoxicity among various folate analogues in human and murine tumor cells in vitro.
Samuels LL; Moccio DM; Sirotnak FM
Cancer Res; 1985 Apr; 45(4):1488-95. PubMed ID: 3978616
[TBL] [Abstract][Full Text] [Related]
12. Biochemical and pharmacologic properties of a new folate analog, 10-deaza-aminopterin, in mice.
Sirotnak FM; DeGraw JI; Chello PL; Moccio DM; Dorick DM
Cancer Treat Rep; 1982 Feb; 66(2):351-8. PubMed ID: 7055818
[No Abstract] [Full Text] [Related]
13. Structural design, biochemical properties, and evidence for improved therapeutic activity of 5-alkyl derivatives of 5-deazaaminopterin and 5-deazamethotrexate compared to methotrexate in murine tumor models.
Sirotnak FM; Schmid FA; Otter GM; Piper JR; Montgomery JA
Cancer Res; 1988 Oct; 48(20):5686-91. PubMed ID: 3167828
[TBL] [Abstract][Full Text] [Related]
14. Polyglutamylation of the dihydrofolate reductase inhibitor gamma-methylene-10-deazaaminopterin is not essential for antitumor activity.
Cao S; Abraham A; Nair MG; Pati R; Galivan JH; Hausheer FH; Rustum YM
Clin Cancer Res; 1996 Apr; 2(4):707-12. PubMed ID: 9816221
[TBL] [Abstract][Full Text] [Related]
15. Enhanced polyglutamylation of aminopterin relative to methotrexate in the Ehrlich ascites tumor cell in vitro.
Matherly LH; Voss MK; Anderson LA; Fry DW; Goldman ID
Cancer Res; 1985 Mar; 45(3):1073-8. PubMed ID: 2578870
[TBL] [Abstract][Full Text] [Related]
16. Activity of the folate analog 10-ethyl, 10-deaza-aminopterin (10-EdAM) against human head and neck cancer xenografts.
Brown DH; Braakhuis BJ; van Dongen GA; van Walsum M; Bagnay M; Snow GB
Anticancer Res; 1989; 9(6):1549-52. PubMed ID: 2627109
[TBL] [Abstract][Full Text] [Related]
17. Similar characteristics of folate analogue transport in vitro in contrast to varying dihydrofolate reductase levels in epithelial cells at different stages of maturation in mouse small intestine.
Sirotnak FM; Moccio DM; Yang CH
Cancer Res; 1984 Nov; 44(11):5204-11. PubMed ID: 6488181
[TBL] [Abstract][Full Text] [Related]
18. Syntheses and antifolate activity of 5-methyl-5-deaza analogues of aminopterin, methotrexate, folic acid, and N10-methylfolic acid.
Piper JR; McCaleb GS; Montgomery JA; Kisliuk RL; Gaumont Y; Sirotnak FM
J Med Chem; 1986 Jun; 29(6):1080-7. PubMed ID: 2423690
[TBL] [Abstract][Full Text] [Related]
19. Dynamics of antifolate transport via the reduced folate carrier and the membrane folate receptor in murine leukaemia cells in vitro and in vivo.
Mauritz R; Peters GJ; Kathmann I; Teshale H; Noordhuis P; Comijn EM; Pinedo HM; Jansen G
Cancer Chemother Pharmacol; 2008 Nov; 62(6):937-48. PubMed ID: 18283461
[TBL] [Abstract][Full Text] [Related]
20. [Tomizine--a new inhibitor of folate metabolism enzymes possessing an antitumor activity].
Sokolova AS; Riabokon' NA; Ershova IuA; Andreeva NA; Nemeriuk MP
Vopr Onkol; 1975; 21(11):45-50. PubMed ID: 174306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
